Principal Financial Group, Inc. · PFG · FY2026 Q1 · Calendar Q2 2026

Principal Financial Posts 13% EPS Growth on Record Retirement Deposits and Specialty Benefits

Principal Financial Group opened fiscal 2026 with 13% adjusted EPS growth to $2.07, beating the $2.01 consensus by roughly 3%. The quarter showed broad-based momentum: retirement transfer deposits grew 35% year-over-year, specialty benefits sales set a record with 24% growth, and Investment Management gross sales reached $37 billion. Management maintained the full-year 2026 outlook of 9-12% EPS growth and 15-17% ROE first introduced last quarter, indicating Q1 results track within but not ahead of the target range. The market response was measured — a 1.6% abnormal move followed by a 4.5% subsequent drift higher. Revenue of $3.52 billion fell short of the $4.12 billion estimate; the provided transcript analysis does not attribute the gap to a specific cause. The stock currently trades at $113.95, above the analyst consensus target of $104.67, suggesting the market is pricing in…

Reported After market closeNASDAQFinancial Services $24.45B market cap
100quality score

Company context

Snapshot as of publication

Principal Financial Group, Inc. engages in the investment management offering business. It offers financial products and services to businesses, individuals, and institutional clients. It operates its business through the following segments: Retirement and Income Solutions, Principal Asset Management, and Benefits and Protection. The Retirement and Income Solutions Segment offers a comprehensive portfolio of products and services for retirement savings along with select products for retirement income. The Principal Asset Management segment provides global investment solutions to institutional, retirement, retail and high net worth investors in the U.S. and select emerging markets. The Benefits and Protection segment includes selling individual life insurance products. The company was founded by Edward A. Temple in 1879 and is headquartered in Des Moines, IA.

Earnings scorecard

Reported versus consensus
Reported EPS $2.07 Consensus $2
EPS surprise +3.0% Reported versus consensus
Reported revenue $3.52B Consensus $4.12B
Revenue surprise -14.6% Reported versus consensus

Earnings History

Estimate Beat Miss Match
PFG EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q1 '24 estimate $1.73 Q1 '24 actual $1.65, miss Q2 '24 estimate $1.84 Q2 '24 actual $1.63, miss Q3 '24 estimate $2.01 Q3 '24 actual $1.76, miss Q2 '25 estimate $1.97 Q2 '25 actual $2.16, beat Q3 '25 estimate $2.20 Q3 '25 actual $2.10, miss Q4 '25 estimate $2.23 Q4 '25 actual $2.19, miss Q1 '26 estimate $2.01 Q1 '26 actual $2.07, beat Q2 '26 estimate $2.34 Q2 '26 actual $2.50, beat Q3 '26 estimate $2.50 Q4 '26 estimate $2.51 Q1 '27 estimate $2.28 Q2 '27 estimate $2.59
Show 1 more >

Analyst Consensus ?

ConsensusHold25 ratings
Bullish520.0%
Neutral1456.0%
Bearish624.0%

Analyst 52W Price Targets

$113.95Current
$64Low
$92.84Average
$125High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Evercore ISI Group In Line In LineMaintainJul 28, 2026
B of A Securities Underperform UnderperformMaintainJul 28, 2026
Wells Fargo Equal Weight Equal WeightMaintainJul 22, 2026
JP Morgan Neutral NeutralMaintainJul 21, 2026
Keefe, Bruyette & Woods Market Perform Market PerformMaintainJul 13, 2026
Jefferies Hold HoldMaintainJul 10, 2026
Barclays Underweight UnderweightMaintainJul 7, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJul 6, 2026
Show 17 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $113.95. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Wells FargoWes Carmichael$113$109.57 -0.8%Jul 22, 2026
Atlantic EquitiesAnalyst unavailable$94$113.09 -17.5%Jul 15, 2026
JefferiesAnalyst unavailable$98$111.67 -14.0%Jul 10, 2026
BarclaysAnalyst unavailable$92$112.55 -19.3%Jul 7, 2026
Piper SandlerJohn Barnidge$125$112.36 +9.7%Jun 24, 2026
Morgan StanleyAnalyst unavailable$107$103.3 -6.1%May 21, 2026
Raymond JamesWilma Burdis$111$101.85 -2.6%May 19, 2026
Evercore ISIAnalyst unavailable$108$99.34 -5.2%Apr 27, 2026
BarclaysAlex Scott$87$97 -23.7%Apr 24, 2026
UBSMichael Ward$94$92.32 -17.5%Apr 9, 2026
See 23 more

Track every rating change on PFG the moment it posts. Free to start.

Start free

Market reaction

event-close to next-session close
Stock move +2.4% Event window
SPY move +0.8% Same window
Abnormal move +1.6% Stock minus SPY
Volume 1.8× Versus trailing sessions
Subsequent drift +4.5% Up to 20 sessions
PFGSPY benchmark

Follow PFG with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Transcript intelligence

What changed

Guidance sentiment shifted from raised to maintained. Last quarter, management introduced the 2026 outlook with 9-12% EPS growth and 15-17% ROE targets; this quarter they reaffirmed those targets without adjustment. Adjusted EPS growth held at 13% year-over-year, consistent with the upper end of the full-year range. Capital returns continued at $375 million in Q1, on pace toward the $1.5-1.8 billion annual deployment target. New developments include a small dental network acquisition in Alabama and discussion of DOL safe-harbor guidance for private-market assets in retirement plans. The prior quarter's notable items — the Chile runoff annuities divestiture and the Saudi Arabia Islamic bank partnership — were not revisited as new announcements.

Guidance delta

Last quarter, management raised guidance and introduced the 2026 outlook targeting 9-12% EPS growth, 15-17% ROE, higher margin goals, and $1.5-1.8 billion in capital deployment. This quarter, guidance was maintained — management reaffirmed confidence in meeting those targets without upward revision. Q1 adjusted EPS growth of 13% sits at the upper end of the full-year range, though management did not signal that first-quarter strength alters the full-year trajectory.

Key takeaways

  • Adjusted EPS grew 13% year-over-year, exceeding the upper end of the full-year target range.
  • Retirement ecosystem transfer deposits grew 35% year-over-year, driven by participant roll-ins and higher deferrals.
  • Specialty Benefits achieved record sales with a 24% year-over-year increase and improved loss ratios.
  • Investment Management delivered record $37 billion in gross sales, up 21% year-over-year, with private-market net inflows of $400 million in the quarter.
  • Capital position remains strong with $1.4 billion in excess capital; the company returned $375 million to shareholders and raised its dividend for the 12th consecutive quarter.

Management priorities

  • Continue AI-driven technology enhancements across the organization.
  • Launch new private-market strategies and expand the active ETF product line.
  • Pursue strategic acquisitions, starting with the dental network in Alabama.
  • Grow global distribution relationships, with focus on Asia and Brazil.
  • Maintain disciplined capital allocation across share repurchases, dividend growth, and targeted capex.

Related earnings events

Financial Services

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-07-30T21:12:33.307132+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T21:12:33.304367+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.